Small Cell Lung Cancer: State of the Art of the Molecular and Genetic Landscape and Novel Perspective

SIMPLE SUMMARY: Small cell lung cancer (SCLC) continues to carry a poor prognosis with a five-year survival rate of 3.5% and a 10-year survival rate of 1.8%. The pathogenesis remains unclear, and there are no known predictive or diagnostic biomarkers. The current SCLC classification as a single enti...

Descripción completa

Detalles Bibliográficos
Autores principales: Denninghoff, Valeria, Russo, Alessandro, de Miguel-Pérez, Diego, Malapelle, Umberto, Benyounes, Amin, Gittens, Allison, Cardona, Andres Felipe, Rolfo, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038650/
https://www.ncbi.nlm.nih.gov/pubmed/33917282
http://dx.doi.org/10.3390/cancers13071723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038650/
https://www.ncbi.nlm.nih.gov/pubmed/33917282
http://dx.doi.org/10.3390/cancers13071723

Ejemplares similares